Please login to the form below

Not currently logged in
Email:
Password:

NHS Commissioning Board appoints 16 local directors

They will provide oversight as new system is implemented across England

England's NHS Commissioning Board has appointed the first 16 of its local directors who will lead the support of clinical commissioning groups and provide an oversight of the new system of commissioning currently being implemented across the country as part of the Health Bill.

Under this new legislation, commissioning control is being handed from primary care trusts and strategic health authorities to GPs, with the NHS Commissioning Board set up to provide national standards and accountability, and ensure the system is “fit for purpose”.

According the NHS Commissioning Board, the new local directors will work with clinical commissioning groups, providing such functions as emergency planning, quality and safety arrangements and stakeholder engagement. The local director will also be a partner on the appropriate health and wellbeing board.

In addition, each local team will support the commissioning of GP services, dental services, pharmacy and certain aspects of optical services.

Once the NHS Commissioning Board takes on full responsibilities in April, 2013, there will be 27 local teams across the country, although the three London teams will be managed by one director, meaning only 25 local directors are to be hired in total.

The remaining nine positions will be filled after a second round of advertising and interviews.

Ian Dalton, chief operating officer and deputy chief executive of the NHS Commissioning Board Authority said: “I am delighted that we have made these key appointments to such important leadership posts.

“This puts us in a position to quickly develop the local presence of the NHS Commissioning Board, building strong relationships with our partners and communities to firmly focus on driving improvement for our patients.”

The appointments so far are:

North
• Cheshire, Warrington and Wirral: Moira Dumma (currently director of commissioning development at NHS Midlands and East SHA Cluster)
• Merseyside: Clare Duggan (currently director of strategic change at NHS Merseyside PCT Cluster)
• Greater Manchester: Mike Burrows (currently chief executive of NHS Greater Manchester PCT Cluster)
• South Yorkshire and Bassetlaw: Andy Buck (currently chief executive of NHS South Yorkshire and Bassetlaw PCT Cluster)
• North Yorkshire and Humber: Chris Long (currently chief executive of NHS North Yorkshire and York PCT Cluster and NHS Humberside PCT Cluster)
• Durham, Darlington and Tees: Cameron Ward (currently director of commissioning development at NHS North of England SHA Cluster)

Midlands and East
• Essex: Andrew Pike (currently chief executive of South Essex PCT Cluster)
• Hertfordshire and the South Midlands: Jane Halpin (currently chief executive of NHS Hertfordshire PCT Cluster)
• Leicestershire and Lincolnshire: David Sharp (currently chief executive of NHS Derbyshire PCT Cluster)
• Derbyshire and Nottinghamshire: Derek Bray (currently chief executive of NHS Nottinghamshire PCT Cluster)
• Shropshire and Staffordshire: Graham Urwin (currently chief executive of NHS Staffordshire PCT Cluster)
• Birmingham and the Black Country: Wendy Saviour (currently director of partnerships at NHS Commissioning Board Authority)

London
• London: Simon Weldon (currently director of operations and delivery at North West London Commissioning Partnership)

South of England
• Surrey and Sussex: Amanda Fadero (currently chief executive of NHS Sussex PCT Cluster)
• Wessex:  Debbie Fleming (currently chief executive of Southampton, Hampshire, Isle of Wight and Portsmouth PCT Cluster)
• Devon, Cornwall and Isles of Scilly: Ann James (currently chief executive of NHS Devon, Plymouth and Torbay PCT Cluster).

23rd July 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CDM London

Brands, categories, relationships, and careers at CDM London - we want to grow them all....

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...